Emisphere Technologies

About:

Emisphere is a pharmaceutical company utilizing its proprietary Eligen Technology to create new oral formulations of therapeutic agents.

Website: http://www.emisphere.com/

Twitter/X: emispherepharma

Description:

Emisphere is a pharmaceutical company utilizing its proprietary Eligen Technology to create new oral formulations of therapeutic agents. Emisphere currently has a number of product candidates in its pipeline at varying stages. There are multiple product candidates in clinical development as well as several pre-clinical development/research programs. The Company considers specific criteria when deciding whether to devote resources to a development program. The markets that Emisphere seeks to enter for a potential product should be substantial. The product candidate should meet a clear unmet medical or market need and the product profile should clearly differentiate Emisphere's products. The Company also considers the level of product development effort in relation to a reasonable return on investment within an acceptable timeframe.

Total Funding Amount:

$42.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Roseland, New Jersey, United States

Founded Date:

1986-01-01

Contact Email:

mgarone(AT)emisphere.com

Founders:

Solomon S. Steiner

Number of Employees:

51-100

Last Funding Date:

2014-08-20

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai